Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218777 · ClinicalTrials.gov registry record · Phase 2
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
A Phase 2 study of Tourette Syndrome and Tic Disorders, sponsored by Tourette Association of America.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 3
- Study locations
NCT00218777 is a Phase 2 study of Tourette Syndrome and Tic Disorders that has completed, run by Tourette Association of America. The registered enrollment target is 120 participants, above the 83-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (45% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT00218777, a Phase 2 study of Tourette Syndrome and Tic Disorders, has completed, sponsored by Tourette Association of America.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will determine the effectiveness of cognitive behavior therapy (CBT) with habit reversal training (HRT) in treating chronic tic disorders (CTDs) in children and adolescents.
Conditions Studied
Interventions
- BEHAVIORAL Comprehensive Behavioral Intervention for Tics
Study Locations (3)
California
- UCLA Child OCD, Anxiety, and Tic Disorders Program - Los Angeles
Maryland
- Johns Hopkins University - Baltimore
Wisconsin
- University of Wisconsin-Milwaukee - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00218777
The ClinicalTrials.gov registry entry for NCT00218777 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 83-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (45% higher). The listed sponsor is Tourette Association of America, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive Behavioral Intervention for Tics is the first listed.
NCT00218777 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Maryland, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00218777 about?
NCT00218777 is a clinical study titled "Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children". This study will determine the effectiveness of cognitive behavior therapy (CBT) with habit reversal training (HRT) in treating chronic tic disorders (CTDs) in children and adolescents.
What is the current status of trial NCT00218777?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2004-12. Estimated completion is 2007-05.
What conditions does trial NCT00218777 study?
This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders.
What interventions are being tested in trial NCT00218777?
The interventions under investigation include: Comprehensive Behavioral Intervention for Tics (BEHAVIORAL).
Who is sponsoring clinical trial NCT00218777?
This trial is sponsored by Tourette Association of America, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00218777 being conducted?
This trial has 3 study locations across California, Maryland, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
RECRUITING · Phase 2
-
CBIT+TMS R33 Phase
RECRUITING · Phase 2
-
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
ACTIVE NOT RECRUITING · Phase 2
-
Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
COMPLETED · Phase 2
-
Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome
COMPLETED · Phase 2
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.